Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology, Expert Review of Vaccines, vol.13, issue.9, pp.1081-1106, 2014. ,
DOI : 10.1586/14760584.2014.944167
Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection, JAMA, vol.308, issue.5, pp.454-456, 2012. ,
DOI : 10.1001/jama.2012.6364
A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States, PLOS Computational Biology, vol.64, issue.4, 2015. ,
DOI : 10.1371/journal.pcbi.1004138.s001
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Nature Genetics, vol.35, issue.1, pp.32-40, 2003. ,
DOI : 10.1038/ng1227
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog, p.45, 2005. ,
Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen, Infection, Genetics and Evolution, vol.10, issue.1, pp.36-49, 2010. ,
DOI : 10.1016/j.meegid.2009.10.007
Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin, Clinical Microbiology and Infection, vol.18, issue.9, pp.340-346, 2012. ,
DOI : 10.1111/j.1469-0691.2012.03925.x
Pertussis resurgence: waning immunity and pathogen adaptation ??? two sides of the same coin, Epidemiology and Infection, vol.18, issue.04, pp.685-694, 2014. ,
DOI : 10.1016/S0264-410X(98)00226-6
Multilocus Sequence Typing of Bordetella pertussis Based on Surface Protein Genes, Journal of Clinical Microbiology, vol.40, issue.6, 1994. ,
DOI : 10.1128/JCM.40.6.1994-2001.2002
Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussisand Bordetella bronchiseptica, Research in Microbiology, vol.160, issue.5, pp.330-336, 2009. ,
DOI : 10.1016/j.resmic.2009.03.006
Comparative genomics of prevaccination and modern Bordetella pertussis strains, BMC Genomics, vol.11, issue.1, pp.10-1186, 2010. ,
DOI : 10.1186/1471-2164-11-627
Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps, PLoS ONE, vol.7, issue.9, 2012. ,
DOI : 10.1371/journal.pone.0046407.s005
Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens, BMC Genomics, vol.13, issue.1, pp.10-1186, 2012. ,
DOI : 10.1093/molbev/msr121
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination, 1074. ,
and pertactin-deficient clinical isolates: lessons for pertussis vaccines, Expert Review of Vaccines, vol.13, issue.9, pp.1135-1146, 2014. ,
DOI : 10.1586/14760584.2014.932254
First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin, Vaccine, vol.27, issue.43, pp.6034-6041, 2009. ,
DOI : 10.1016/j.vaccine.2009.07.074
Isolates from Infants, France, Emerging Infectious Diseases, vol.19, issue.3, pp.471-474 ,
DOI : 10.3201/eid1903.121475
Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population, Microbiology, vol.160, issue.Pt_5, pp.962-969, 2014. ,
DOI : 10.1099/mic.0.074690-0
Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage, Clinical Infectious Diseases, vol.60, issue.2, pp.223-227, 2015. ,
DOI : 10.1093/cid/ciu788
A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussis, Journal of General Microbiology, vol.63, issue.2, pp.211-220, 1970. ,
DOI : 10.1099/00221287-63-2-211
cultivation for vaccine production, Biotechnology and Bioengineering, vol.81, issue.7, pp.900-908, 2009. ,
DOI : 10.1002/bit.22326
Purification of RNA Using TRIzol (TRI Reagent), Cold Spring Harbor Protocols, vol.2010, issue.6, 2010. ,
DOI : 10.1101/pdb.prot5439
The ongoing evolution of qPCR, Methods, vol.50, issue.4, pp.215-216, 2010. ,
DOI : 10.1016/j.ymeth.2010.02.005
R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing, 2012. ,
Is the Sequenced Bordetella pertussis Strain Tohama I Representative of the Species?, Journal of Clinical Microbiology, vol.46, issue.6, pp.2125-2128, 2008. ,
DOI : 10.1128/JCM.02484-07
Pertussis: a matter of immune modulation, FEMS Microbiology Reviews, vol.35, issue.3, pp.441-474, 2011. ,
DOI : 10.1111/j.1574-6976.2010.00257.x
Genomic Analysis of Isolates From the United Kingdom 2012 Pertussis Outbreak Reveals That Vaccine Antigen Genes Are Unusually Fast Evolving, Journal of Infectious Diseases, vol.212, issue.2, pp.294-301, 2015. ,
DOI : 10.1093/infdis/jiu665
SNP-Based Typing: A Useful Tool to Study Bordetella pertussis Populations, PLoS ONE, vol.78, issue.5, p.20340, 2011. ,
DOI : 10.1371/journal.pone.0020340.s005
Pertactin-negative Bordetella pertussis strains in Canada: Characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years, Int. J. Infect. Dis, vol.28, pp.65-69, 2014. ,
Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, Euro Surveill. Bull. Eur. Mal. Transm. 2014, vol.19, pp.17-27, 1996. ,
Molecular Epidemiology of the Pertussis Epidemic in Washington State in 2012, Journal of Clinical Microbiology, vol.52, issue.10, pp.3549-3557, 2014. ,
DOI : 10.1128/JCM.01189-14
Population diversity among Bordetella pertussis isolates, United States, Emerg. Infect. Dis, vol.18, pp.1935-2009, 2012. ,
Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity, Microbiology, vol.147, issue.11, pp.2885-2895, 2001. ,
DOI : 10.1099/00221287-147-11-2885
Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains, PLoS ONE, vol.9, issue.6, p.66150, 2013. ,
DOI : 10.1371/journal.pone.0066150.s003
Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally, PLoS ONE, vol.2014, issue.9, p.84523 ,
Strains with Increased Toxin Production Associated with Pertussis Resurgence, Emerging Infectious Diseases, vol.15, issue.8, pp.1206-1213, 2009. ,
DOI : 10.3201/eid1508.081511
The RNA Chaperone Hfq Is Required for Virulence of Bordetella pertussis, Infection and Immunity, vol.81, issue.11, pp.4081-4090, 2013. ,
DOI : 10.1128/IAI.00345-13
reveals requirement of RNA chaperone Hfq for Type III secretion system functionality, RNA Biology, vol.34, issue.2, pp.175-185, 2015. ,
DOI : 10.1093/nar/29.9.e45
Detection of small RNAs in Bordetella pertussis and identification of a novel repeated genetic element, BMC Genomics, vol.173, issue.1, pp.10-1186, 2011. ,
DOI : 10.1186/1471-2164-12-207
Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin, Infect. Immun, vol.60, pp.2380-2385, 1992. ,
Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infection and immunity, pp.2901-2909, 2010. ,
A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells, New Microbiol, vol.32, pp.159-166, 2009. ,
Role of Adhesins and Toxins in Invasion of Human Tracheal Epithelial Cells by Bordetella pertussis, Infection and Immunity, vol.68, issue.4, pp.1934-1941, 2000. ,
DOI : 10.1128/IAI.68.4.1934-1941.2000
entry into respiratory epithelial cells and intracellular survival, Pathogens and Disease, vol.69, issue.3, pp.194-204, 2013. ,
DOI : 10.1111/2049-632X.12072
Nonhuman Primate and Human Challenge Models of Pertussis, Journal of Infectious Diseases, vol.209, issue.suppl 1, pp.20-23, 2014. ,
DOI : 10.1093/infdis/jit493
Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine, PLoS Pathogens, vol.171, issue.4, p.1003264 ,
DOI : 10.1371/journal.ppat.1003264.s008
Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine1Financial support for the present study was provided by the Institut Pasteur Fondation and SmithKline Beecham Biologicals. All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1, Vaccine, vol.17, issue.20-21, pp.2651-2660, 1999. ,
DOI : 10.1016/S0264-410X(99)00038-9
Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model, Vaccine, vol.23, issue.46-47, pp.5333-5341, 2005. ,
DOI : 10.1016/j.vaccine.2005.06.021